HIGHFDA DEVICE

Bard Peripheral Vascular Venclose DigiRF Generator Recall Affects 1,725 Units Worldwide

Bard Peripheral Vascular recalled 1,725 Venclose digiRF Generators with software version 3.35. The recall centers on a catheter verification feature that can produce false positives and disable compatible EVSRF catheters. The worldwide distribution includes the United States. Patients and healthcare providers should stop using the device and await further instructions from the manufacturer.

Official notice
Bard Peripheral VascularHealth & Personal CareMedical DevicesUDI-DI: 00858254006022. Generator Software Version 3.35

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
August 21, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 21, 2025
Hazard Level
HIGH
Brand
Bard Peripheral Vascular
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Bard Peripheral Vascular
Product type
RF Generator
Model numbers
UDI-DI: 00858254006022. Generator Software Version 3.35
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 21, 2025

  2. Reported by FDA DEVICE

    October 8, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Software version 3.35 of the Venclose digiRF Generator incorporates a catheter verification feature specifically designed to detect internal wiring anomalies in Venclose EVSRF Ablation Catheters prior to clinical use. This automated diagnostic check is executed immediately upon catheter connection to the generator, occurring before the procedure interface becomes accessible. When a catheter fails this verification process, the generator displays a Red X indicator on the screen without accompanying error codes, effectively disabling catheter functionality. However, BD has determined that software version 3.35 generates false positive failures due to temperature-dependent verification parameters, incorrectly flagging properly functioning Venclose EVSRF Ablation Catheters as defective when the catheter temperature is not at steady state during the check initiation.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Bard Peripheral Vascular Inc or your healthcare provider for instructions. Notification method: Letter

About This Product

Venclose digiRF Generator is a multi-voltage RF energy delivery system used with Venclose EVSRF Ablation Catheters for temperature-controlled vein ablation.

Why This Is Dangerous

Software 3.35 verification may falsely flag working catheters as defective, disabling use before procedures begin.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

High hazard potential due to device functioning being disabled pre-procedure, requiring clinical oversight and potential schedule disruption.

Practical Guidance

How to identify if yours is affected

  1. Check model number VCRFG1 and software version 3.35
  2. Confirm UDI-DI: 00858254006022 on device labeling
  3. Look for a Red X indicator on screen during catheter connection

Where to find product info

Manufacturers' recall notice and FDA enforcement page; serial numbers on device label

What timeline to expect

Remediation timeline not specified; expect facility-level guidance and replacement options

If the manufacturer is unresponsive

  • Escalate to hospital procurement or medical device distributor
  • File a complaint with FDA via MedWatch if manufacturer unresponsive
  • Seek alternative vendor guidance for temporary clinical workflows

How to prevent similar issues

  • Verify software version before procedures
  • Maintain software update logs
  • Coordinate with procurement for replacement options
  • Keep records of all communications and device identifiers

Documentation advice

Retain recall notice, device labels, UDI-DI, and correspondence with vendor

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model VCRFG1 with software 3.35. Distributor worldwide; US distribution in multiple states listed. 1,725 units recalled.

Reported Incidents

No specific injuries or patient harm data are provided in the recall notice. This entry notes a high-hazard warning but does not report injuries.

Key Facts

  • Software 3.35 verification feature
  • False positives temperature-dependent
  • Red X indicator disables catheter
  • Worldwide distribution including numerous US states

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETSPREGNANT
Injury Types
ELECTRICALOTHER

Product Details

Model Numbers
UDI-DI: 00858254006022. Generator Software Version 3.35
Affected States
ALL
Report Date
October 8, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more